×
Brainsway Total Liabilities 2018-2025 | BWAY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Brainsway total liabilities from 2018 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
View More
Brainsway Total Liabilities 2018-2025 | BWAY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Brainsway total liabilities from 2018 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$230.9B
Boston Scientific (BSX)
$156.3B
Stryker (SYK)
$149.6B
EssilorLuxottica (ESLOY)
$141.3B
Medtronic (MDT)
$119B
Lonza Group Ag (LZAGY)
$49.8B
Haleon (HLN)
$43.9B
ResMed (RMD)
$40.2B
Agilent Technologies (A)
$35.7B
GE HealthCare Technologies (GEHC)
$33.7B
Terumo (TRUMY)
$26.6B
Koninklijke Philips (PHG)
$26.6B
Insulet (PODD)
$23.9B
Zimmer Biomet Holdings (ZBH)
$21B
Smith & Nephew SNATS (SNN)
$16.4B
Baxter (BAX)
$12.7B
Sunny Optical Technology (SNPTF)
$10.8B
Demant (WILYY)
$8.1B
Bio-Rad Laboratories (BIO)
$8.1B
Lantheus Holdings (LNTH)
$3.7B
Envista Holdings (NVST)
$3.5B
Shandong Weigao Medical Polymer (SHWGF)
$3.5B
Prestige Consumer Healthcare (PBH)
$3.3B
Perrigo (PRGO)
$3.3B
ICU Medical (ICUI)
$3.2B
Haemonetics (HAE)
$2.6B
Acuren (TIC)
$2.3B
Curaleaf Holdings (CURLF)
$2.2B
LeMaitre Vascular (LMAT)
$2.2B
QuidelOrtho (QDEL)
$1.9B